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Cervicalcancer(CC)isthethirdmostcommoncancerinwomenworldwide;however,CCisapreventabledisease,andmucheﬀort
should be done to prevent it. Persistence of high-risk HPV infection is the strongest epidemiologic risk factor for CC, however it
is not suﬃcient for development of the disease it cofactors should be present. In 2004; IARC listed cervical cancer among those
causally related to smoking. Smoking interferes with incidence and prevalence of HPV infection and is associated with cervical
intraepithelial neoplasia and invasive CC. Multiple factors seem to intervene on cervical carcinogenesis related with tobacco,
especially by direct local carcinogenic eﬀect and local immunosuppression. Smoking addition is also closely related with other
confounding factors, like unfavorable psychosocial events, systemic immunity, contraception, and nutrition, which got diﬃcult
epidemiologicevaluationofsmokingroleoncervical carcinogenesis.Smokinghabitsshouldbetakeninaccountinclinicalpractice
and in research concerning CC.
1.Introduction
Cervical cancer (CC) is the third most common cancer in
women, and the seventh overall, with an estimated 530000
new cases in 2008. More than 85% of the global burden
occurs in developing countries, where it accounts for 13% of
all female cancers. Cervical cancer is responsible for 275000
deaths in 2008, about 88% of which occur in developing
countries: 53000 in Africa, 31700 in Latin America and the
Caribbean, and 159800 in Asia [1]. However, CC is prevent-
able disease, and much eﬀort should be done to prevent it.
It is now well-established that persistence of Human Pa-
pillomavirus (HPV) infection is the strongest epidemiologic
factor associated with intraepithelial neoplasia and cancer
of cervix [2–5], and it is considered a necessary cause for
development of the disease but not suﬃcient. Exogenous or
endogenous factors had been identiﬁed to, in conjunction
with HPV infection, inﬂuence the risk for CC. As Castell-
sagu` ea n dM u ˜ noz [6] suggested, cofactors may be classiﬁed
into three groups: (1) environmental or exogenous cofactors,
includinguseoforalcontraceptives(OCs),tobaccosmoking,
diet, cervical trauma, coinfection with human immunodeﬁ-
ciencyvirus (HIV) and othersexually transmitted agents;(2)
viralcofactors,suchasinfectionbyspeciﬁctypes,coinfection
with other types, HPV variants, viral load, and viral inte-
gration; (3)host cofactors, includingendogenoushormones,
genetic factors such as human leukocyte antigen and other
host factors related to the host’s immune response.
WinkelsteinJr.[7]in1977wastheﬁrsttoputthehypoth-
esis that smoking is a risk factor for cervical cancer. Since
then, the action of tobacco on cervical carcinogenesis has
been a matter of scientiﬁc debate.
The objective of this paper is to update the state of the
science about smoking and cancer of the cervix.
2.Materialand Methods
It was checked up in PubMed/Medline and Embase data-
bases, studies written in English with keywords: cervical can-
cer; cervix; CIN; HPV; tobacco; smoking and smoke. Only
meta-analysis and ormulti-institutional studieswere consid-
ered for analysis.
3.Results
Plummer et al. reported the ﬁrst multicentric case-control
study in 2003 [8]. In analyzing eight studies on invasive2 ISRN Obstetrics and Gynecology
cancer and two on carcinoma in situ, conducted by Inter-
national Agency for Research on Cancer (IARC), between
1985 and 1997, the authors conclude that ever-smokers
have an excess risk of cervical cancer that persists after
controlling for the strong eﬀect of HPV and for other
potential cofactors of progression from infection to cancer,
and they suggest that squamous cell carcinoma of the
cervix should be added to the list of tobacco associated
cancers, while for adenocarcinoma, further data should be
warranted.
In 2004, IARC revisited its previous conclusions and
listed cervical cancer among those causally related to smok-
ing [9].
In 2006, a collaborative reanalysis of 12 studies on CC
[10],enrolling 8,097casesofsquamouscellcarcinoma, 1,374
women adenocarcinoma, and 26,445 women without carci-
noma of the cervix, showed that there are no substantial dif-
ferences between the two most common histological types of
invasive cervical cancer with respect to the role of number of
sexualpartners,ageatﬁrstintercourse,ageatﬁrstbirth,body
mass index, and use of oral contraceptives. The exception
was current tobacco smoking, which is associated with an
increased risk of squamous cell but not for adenocarcinoma
of the cervix, in agreement with other studies [11, 12].
Vaccarella etal.[13]in2008reported apooled analysisof
13 IARC HPV prevalence survey in 11 countries worldwide,
carried out between 1993 and 2005. They concluded that
current tobacco smoking was associated with a signiﬁcant,
although moderate, increased risk of prevalent HPV infec-
tion.Among currentsmokers, therisk ofbeingHPV-positive
increased with increasing number of cigarettes smoked per
day,andwomenwhoreportedtosmoke15ormorecigarettes
daily had a 2-fold risk of HPV positivity as compared
with never-smokers. These results have shown that smoking
habits interfere with prevalence of HPV infection in agree-
ment with reported in previous studies [14–16].
Syrj¨ anen et al. [17], in 2007, in analyzing a cohort of
3,187 women, conclude that cigarette smoking was not an
independent risk factor of CIN2+, except for those patients
whotestedforHR-HPV(high-risk HPV),andcurrentsmok-
ing remains an independent predictor for those patients in
a multivariate model, in agreement with previous study of
Harris et al. in 2004, [18] that found among women with
oncogenic HPV infection, smoking was associated with risk
for both CIN1 and CIN2-3. Of the three smoking measures
(smoking status, pack years of exposure, and number of
cigarettes per day), number of cigarettes per day (>10 ciga-
rettes) was the most strongly associated with risk for CIN1
and CIN2-3. In this study, association between cigarettes
smoked by day and CIN did not appear to be mediated by an
immunologic response. Those studies suggest that smoking
has a special adverse eﬀe c to nH R - H P Vd r i v e nc e r v i c a lc a r -
cinogenesis.
A recent study [19], published in 2010, conducted on
2,011 women, 15–19 years old, recruited from 1988 to 1992
thenregularly followed until1997,concludedthatthere isno
evidencetosuggestthattherisk ofacquiringa HPV infection
of any type, or a HPV16 or HPV18 infection, increases with
either pack years of exposure to smoking or duration of
current smoking episode, suggesting that smoking is not a
important risk factor for HR-HPV infection.
Xi et al. in 2009 [20] reported an analysis of 1,050
women HPV16 and/or HPV18 positives for viral DNA load,
enrolled into the ASCUS-LSIL Triage Study. The authors
concluded that higher HPV16 and HPV18 DNA load was
associated with status of current, but not former, smoker.
Among current smokers, the viral load did not appear to
vary appreciably by the intensity and duration of cigarette
smoking, in accordance,with previousstudy ofGunnell etal.
[21] in 2006, that in testing for HPV16 DNA presence in
ﬁrst archival cervical smears from 375 cases of in situ cervical
squamous carcinoma (CIS)and in 363controls, it was found
that current smokers with a high HPV16 viral load at time
of ﬁrst smear were at a particularly increased risk (27-fold)
compared with current smokers without HPV-infection.
4.Discussion
Some molecular mechanisms have been suggested through
why smoking may contribute towards cervical carcinogen-
esis: one involves direct exposure of the deoxyribonucleic
acid (DNA) in cervical epithelial cells to nicotine and
cotinine, and the other involves exposure to metabolic
products resulting from the reactions of other components
of cigarettes such as aromatic polycyclic hydrocarbons and
aromatic amines. [22, 23]. Cervical mucus of smokers con-
tains measurable amounts of cigarette constituents and their
m e t a b o l i t e ss u c ha sb e n z o [ a]pyrene (BaP) [24], nicotine,
and nicotine derived nitrosamines 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone [25] .B a Pu pr e g u l a t i o no fH P V
genome ampliﬁcation may increase the probability of viral
DNA integration into the host genome, a milestone in the
development of cervical cancer [26]. The in vivo eﬀects of
long-term nicotine exposure could aﬀect persistent cellular
proliferation,inhibition ofapoptosis, and stimulationof vas-
cular endothelial growth factor, with increased microvessel
density [27]. Other mechanisms that may explain smoking-
related carcinogenesis are related with abnormalities in the
systemic and peripheral immune systems of smokers, that
include unbalanced systemic production of pro- and anti-
inﬂammatory cytokines [28], elevated numbers of cyto-
toxic/suppressor T lymphocytes, suppression of T lympho-
cyte activity, diminished numbers of helper T lymphocytes,
decreased numbers of natural killer lymphocytes and low
levels of immunoglobulins other than immunoglobulin
E( I g E )[ 29]. These eﬀects may result from substantial
decreased numbers of Langerhans cells in the cervix of
smokers [30, 31]. Aberrant HPV-induced DNA methylation
may be another mechanism to explain cervical smoking-
related carcinogenesis. In vitro studies in untransformed
and transformed cell lines show that short-term exposure
to nicotine or cigarette smoke extract is followed by
changes in the expression of the DNA methyltransferases
DNMT1, DNMT3A,and DNMT3B.Aberrant methylation of
the tumour suppressor gene, p16 (CDNK2A), is strongly
associated with current smoking in women with squamous
cell cervical cancers and high-grade CIN [32].ISRN Obstetrics and Gynecology 3
Intriguing studies analyzing wood-smoke eﬀect on cer-
vical carcinogenesis have shown that, among HPV-positive
women, a dose-response relationship is observed for expo-
sure to wood smoke and cervical cancer that persisted in
multivariate analysis [33], and chronic exposure to wood
smoke signiﬁcantly increased the risk of CIN III, suggesting
that chronic inhalation of carcinogens derived from wood
smoke could have an eﬀect on the progression to cervical
cancer, similar to that observed for cigarette smoking [34].
Probably the smoking eﬀect on cervical carcinogenesis is not
tobacco-speciﬁc.
Smoking seems to aﬀect negatively the early natural
history of HPV infections. The regression of Low Squamous
Intraepithelial Lesions (LSIL) within 2 years is signiﬁcantly
lower in smokers than in never-smokers [35].
Smoking aﬀecting clearance HPV infection remains a
conﬂicting issue. For some authors, smoking have no inﬂu-
ence in duration of HPV infection [19], for others tobacco
delays the clearance of HPV infection [36, 37].
Covalent alterationofDNAto formDNAadductsis con-
sidered an early step in chemical carcinogenesis and, there-
fore, detection of DNA adducts provides evidence of expo-
sure of the cervix to carcinogens. Prokopczyk et al. [38]h a d
shown, in accordnce with previous studies, that signiﬁcantly
higherDNAadductlevelsarepresentinthecervixofsmokers
as compared with nonsmokers, providing molecular evi-
dence of smoking-related carcinogenic agents that aﬀects
the DNA of the cervical epithelium. However, the authors
reported no signiﬁcant diﬀerences in smoking-related DNA
damage (DNA adduct levels) between HPV-positive and
HPV-negative smokers, suggesting that smoking DNA dam-
age is not related with HPV infectivity.
Genetic susceptibility to smoking is an important issue.
Cervical cancer risk in smokers may be modiﬁed by genetic
variants, as that described to interleukin 2 [39]o rt o8 q 2 4
chromosome polymorphisms [40]. In a recent study [41],
the tumor suppressors p53, the fragile histidine triad and the
interleukin-10wereunder-expressed,andthecyclooxygenas-
e-2 and the Ki-67were over-expressed in smoking, compared
with nonsmoking women with CIN.
Familial and social factors are determinant for smoking
attitudes. Being older, being divorced, having friends/family
who smoke, and having parents who smoke are all associated
with ever smoking, and friends are the primary factor
inﬂuencing ever smoking, especially among younger women
[42]. Smokers seem to have lower compliance for cervical
cancer screening, the most powerful weapon against cervical
cancermortality. Smokersheldlesspositiveattitudestowards
cervical screening than did nonsmokers [43], and the
level of nicotine dependence is also signiﬁcantly related to
compliance with screening recommendations; women with
higher levels of dependence are less likely to be compliant
[44].
Unhealthy life style, negatively rated life events, lack of
social support, coping style, and distress, often associated
with smoking, alcoholabuse, and illegal drugsaddition, have
been reported as risk factors for cervical cancer [45–47],
especially among low-educated women [48, 49].
Hormonal contraception is implicated on cervical cancer
development. Appleby et al. [50], in analyzing 24 studies
worldwide that included 16,573 women with cervical cancer
and 35,509 without cervical cancer, concluded that the rela-
tiverisk of cervicalcanceris increased in currentusers of oral
contraceptives, and that increased risk is higher in current
smokers women.
Nutritionisanother importantfactor thatseems toinﬂu-
ence cervical carcinogenesis. Oxidative stress induced by
deﬁciencies in antioxidant micronutrients is likely to change
normal redox balance and transform the HPV-infected cells
toward a carcinogenic process in the cervix [51]. Folate is
a well-studied micronutrient with eﬀect on cervical car-
cinogenesis. Reduced immunocompetence associated with
deﬁciencies of folate and vitamin B12 could increase the risk
of infection and persistence with multiple types or higher
viral loads of HR-HPVs [52–54].
Higher prevalence rates of HPV have also been found in
HIV-seropositive women, proportional to their level of im-
munosuppression [55–57]. HIV-seropositive women, and
particularly the current smokers, are at signiﬁcantly elevated
risk for thedevelopmentand recurrence of precancerousand
cancerouscervical disease [58, 59], especially those who have
lower levels of TH cells. It has been shown that TH cells
are involved in the defense against HPV-transformed cells
[60]. Hence, immunosuppression in general, and depletion
of TH cells in particular, may interact with HPV infection
to increase the risk of cervical cancer. Marijuana usage is
anotherdescribedfactorthatpotenciestobaccoimmunosup-
pression [61].
Smoking also aﬀects survival among women diagnosed
with cervical cancer. Recently, Coker et al. [62], in analysing
2661 women diagnosed with invasive cervical cancer from
1995–2005, found that, after adjustment for age and stage at
diagnosis, cell type, rural residence, race, insurance coverage,
and treatment-received, current smoker, were 35% more
likely to die of any cause and 21% more likely to die of cer-
vical cancer compared with known nonsmoking cases, in
accordance with previous studies. Unfortunately, few smok-
ers with cervical cancer quit or decreased consumption dur-
ing treatment [63].
5.Conclusions
All meta-analyses and multi-institutional studies point out
that smoking is an important cofactor for cervical squamous
cancer and probably also for cervical adenocarcinoma.
Acquisition of HR-HPV infection seems to be a smoking
independent event; however, progression of the acquired
infection is negatively aﬀected by current smoking. Former
s m o k i n gs e e m st ob en os oi m p o r t a n t .
The action mechanisms of smoking on HPV driven cer-
vical carcinogenesis seem to be complex and multifactorial.
In current smokers, genetic, immunologic, and dietary fac-
tors may be associated with cervicalepithelium susceptibility
for HPV carcinogenic eﬀect,butwomens unhealthy lifestyles
seem to be major factors associated with cervical carcin-
ogenesis. What is much determinant for cervical cancer4 ISRN Obstetrics and Gynecology
susceptibility: tobacco action by its own or women health
or behaviour associated with smoking habits? Until now,
a scientiﬁc-based answer is lacking. Epidemiologic, clinical,
and laboratorial research is needed to elucidate this unsolved
topic.
In order to prevent cervical cancer and to improve ther-
apy results, the practitioner should understand negative ef-
fects of tobacco on cervical carcinogenesis, and in those cur-
rent smoking women with diagnosis of cervical HPV infec-
tionorCIN,andhemusthaveanactiveinterventiontoinvite
them to quit smoking habits.
The researchers on cervical cancer should be aware that
smoking habits are a major cofactor on cervical HPV driven
carcinogenesis, and an important confounder factor for
research. Smoking eﬀects should be taken in account by all
researchers in their studies.
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